Glutenic enteropathy (GEP) frequently causes liver issues, including biochemical and morphological changes. Early intervention with a gluten-free diet and liver support is crucial for managing these complications.
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Glutenic enteropathy (GEP), also known as celiac disease, is an autoimmune disorder triggered by gluten ingestion.
Liver involvement is a recognized, yet often overlooked, complication of GEP.
Understanding the spectrum of liver manifestations in GEP is essential for comprehensive patient management.
Purpose:
To investigate the prevalence of clinical, biochemical, and morphological liver abnormalities in patients with GEP.
To explore the relationship between liver alterations, GEP duration, and the severity of malabsorption syndrome (MAS).
Summary:
116 GEP patients underwent clinical, laboratory, and imaging assessments, including liver biopsies.
Clinical signs of liver affection were observed in 7.2% of patients.
Hyperaminotransferasemia was noted in 48.4% of new GEP cases and 18.1% on a gluten-free diet, correlating with MAS severity.
Morphological liver changes included fatty dystrophy, hepatitis, steatohepatitis, and fibrosis.
Early, adequate therapy for GEP, including a strict gluten-free diet and metabolic correction, showed the most effectiveness in addressing liver complications.
Impact:
Highlights the significant association between GEP and liver pathology.
Emphasizes the need for routine liver function monitoring in GEP patients.
Suggests that prompt and comprehensive treatment of GEP can mitigate liver damage and improve outcomes.